Cancer costs EU £99bn per year
Friday 28 September 2012
Cancer costs European countries 124 billion euros (£99 billion) every year, according to the first estimate of the full economic burden of the disease in the EU.
Lung cancer incurred the biggest total cost, amounting to 19 billion euros (£15 billion). This was mostly the result of losses caused by patients dying prematurely.
For healthcare alone, the most expensive disease was breast cancer. At six billion euros (£5 billion), it was responsible for 13% of cancer healthcare costs.
Scientists pooled together data from the World Health Organisation, the Organisation for Economic Co-operation and Development (OECD), national surveys, and government departments.
From their analysis they worked out the combined cost of treatment, social care, and lost productivity due to cancer.
Direct healthcare costs were also calculated for each of the 27 countries included in the research.
They showed that Lithuania spent the least on cancer healthcare, around 7,550 euros (£6,026) per patient with a per capita cost of 32 euros (£25.50) per person per year.
Germany had the highest healthcare cost, spending an average of 28,269 euros (£22,563) on every cancer case. It had a per-capita expenditure of 165 euros (£132).
The UK spent 17,619 euros (£14,062) per case and 88 euros (£70) per head of population.
Study leader Dr Ramon Luengo-Fernandez, from Oxford University, said: "Cancer poses a considerable economic burden not only to healthcare systems but to other areas of the economy, including productivity losses through early mortality and time off work, and relatives who have to forego work/leisure to care for cancer patients.
"Healthcare systems will have a good idea, I expect, of the healthcare costs of providing cancer care to their patients. However, the productivity losses and informal care costs associated with cancer will be less well understood and their magnitude less appreciated."
The findings were presented today at the European Society for Medical Oncology's annual meeting in Vienna.
The scientists focused on four of the most common cancers, lung, bowel, breast and prostate.
Commenting on the results Professor Peter Boyle, president of the International Prevention Research Institute in Lyon, France, said: "It is essential that the economic impact of cancer on a community is known, understood and placed in its perspective."
filmNymphomaniac is more Carl Dreyer than sexploitation of Russ Meyer
elephant appealThe first 23 lots in our charity auction have now gone. But there are 22 more still up for grabs
scienceScientists find the answer to a question that even puzzled Darwin
arts + entsThe 'Friends' actor on his new role as campaigner on addiction issues
Geoffrey Macnab: The Wolf of Wall Street's account of white-collar excess is A Rake’s Progress on steroids
scienceThe new development in bio-printing technology could be used in the future to restore lost vision - though years of research still await
architectureThe design collective which has stuck two fingers up at the modernists will call it quits at Venice
... But if you’re one of those poor souls offended by Jennifer Lopez’s choice of leotard, Grace Dent want you to get a bloody grip
Life & Style blogs
The 10 Best Scotch Whiskies
Breakthrough in quantum computing smashes previous records
Facebook 'self-censorship': study records when you don't post to find more ways to share
Vitamin pills are a waste of money, offer no health benefits and could be harmful - study
Physicists discover 'clearest evidence yet' that the Universe is a hologram
- 1 Facebook 'self-censorship': study records when you don't post to find more ways to share
- 2 Sun will 'flip upside down' within weeks, says Nasa
- 3 British prisoner Dr Abbas Khan found dead in Syrian jail days before he was due to be handed over to MP George Galloway
- 4 Vitamin pills are a waste of money, offer no health benefits and could be harmful - study
- 5 Children evacuated from swimming pool after prosthetic leg mistaken for paedophile
- < Previous
- Next >
£55000 - £60000 per annum + Benefits: Harrington Starr: Senior C# ASP.NET Deve...
£60000 - £70000 per annum + Benefits: Harrington Starr: Senior QA Engineer Tes...
£50000 - £60000 per annum + Benefits: Harrington Starr: QA Automation Explorat...
£50000 - £75000 per annum + benefits + bonus: Harrington Starr: Implementation...